Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Bob D Brown. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Bob D Brown zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:DRNA / Dicerna Pharmaceuticals Inc | Chief Scientific Ofr., EVP R&D | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Bob D Brown. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Bob D Brown ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -68 100 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -121 300 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -75 000 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -165 050 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -180 000 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -105 000 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
D - Sale to Issuer | -85 000 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
D - Sale to Issuer | -11 325 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
D - Sale to Issuer | -25 950 | 0 | -100,00 | ||||
| 2021-12-29 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
U - Other | -2 367 | 0 | -100,00 | 38,25 | -90 538 | ||
| 2021-12-17 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
M - Exercise | -3 775 | 11 325 | -25,00 | ||||
| 2021-12-17 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
F - Taxes | -1 675 | 2 367 | -41,44 | 38,05 | -63 734 | 90 064 | |
| 2021-12-17 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 3 775 | 4 042 | 1 413,86 | ||||
| 2021-11-22 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -24 936 | 0 | -100,00 | ||||
| 2021-11-22 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -24 936 | 267 | -98,94 | 37,94 | -946 072 | 10 130 |
| 2021-11-22 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 24 936 | 25 203 | 9 339,33 | 3,42 | 85 281 | 86 194 | |
| 2021-09-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -21 250 | 267 | -98,76 | 21,06 | -447 516 | 5 623 |
| 2021-08-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 24 936 | -25,00 | ||||
| 2021-08-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 312 | 21 517 | -27,87 | 37,38 | -310 678 | 804 241 |
| 2021-08-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 33 248 | -20,00 | ||||
| 2021-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -1 066 | 21 517 | -4,72 | 37,85 | -40 344 | 814 345 |
| 2021-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -7 246 | 22 583 | -24,29 | 37,30 | -270 297 | 842 411 |
| 2021-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-06-15 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -10 000 | 85 000 | -10,53 | ||||
| 2021-06-15 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -10 000 | 21 517 | -31,73 | 34,00 | -340 000 | 731 578 |
| 2021-06-15 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 10 000 | 31 517 | 46,47 | 9,09 | 90 900 | 286 490 | |
| 2021-06-08 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -10 000 | 95 000 | -9,52 | ||||
| 2021-06-08 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -10 000 | 21 517 | -31,73 | 33,00 | -330 000 | 710 061 |
| 2021-06-08 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 10 000 | 31 517 | 46,47 | 9,09 | 90 900 | 286 490 | |
| 2021-06-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 41 560 | -16,67 | ||||
| 2021-06-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -342 | 21 517 | -1,56 | 32,02 | -10 950 | 688 899 |
| 2021-06-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -7 970 | 21 859 | -26,72 | 30,88 | -246 128 | 675 045 |
| 2021-06-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-05-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 49 872 | -14,29 | ||||
| 2021-05-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -24 | 21 517 | -0,11 | 31,66 | -760 | 681 228 |
| 2021-05-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -1 135 | 21 541 | -5,01 | 31,01 | -35 197 | 667 993 |
| 2021-05-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -7 153 | 22 676 | -23,98 | 30,16 | -215 716 | 683 849 |
| 2021-05-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -10 000 | 105 000 | -8,70 | ||||
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -10 000 | 21 517 | -31,73 | 32,00 | -320 000 | 688 544 |
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 10 000 | 31 517 | 46,47 | 9,09 | 90 900 | 286 490 | |
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -10 000 | 115 000 | -8,00 | ||||
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -10 000 | 21 517 | -31,73 | 31,00 | -310 000 | 667 027 |
| 2021-05-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 10 000 | 31 517 | 46,47 | 9,09 | 90 900 | 286 490 | |
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -16 630 | 5 246 | -76,02 | ||||
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 16 630 | 43 147 | 62,71 | 2,97 | 49 391 | 128 147 | |
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -5 246 | 0 | -100,00 | ||||
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -3 066 | 74 808 | -3,94 | ||||
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 5 246 | 29 829 | 21,34 | 2,97 | 15 581 | 88 592 | |
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 3 066 | 24 583 | 14,25 | 3,42 | 10 486 | 84 074 | |
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 66 496 | -11,11 | ||||
| 2021-04-05 |
|
4/A | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-04-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 58 184 | -12,50 | ||||
| 2021-04-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -188 | 21 517 | -0,87 | 26,50 | -4 981 | 570 093 |
| 2021-04-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 124 | 21 705 | -27,24 | 25,85 | -210 044 | 561 178 |
| 2021-04-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 3,42 | 28 427 | 102 015 | |
| 2021-03-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 91 746 | -8,31 | ||||
| 2021-03-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -783 | 21 517 | -3,51 | 29,49 | -23 090 | 634 513 |
| 2021-03-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -7 529 | 22 300 | -25,24 | 28,90 | -217 611 | 644 539 |
| 2021-03-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 9,09 | 75 556 | 271 146 | |
| 2021-02-04 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 312 | 100 058 | -7,67 | ||||
| 2021-02-04 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 312 | 21 517 | -27,87 | 25,00 | -207 800 | 537 925 |
| 2021-02-04 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 312 | 29 829 | 38,63 | 9,09 | 75 556 | 271 146 | |
| 2021-01-27 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -16 630 | 108 370 | -13,30 | ||||
| 2021-01-27 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -21 630 | 21 517 | -50,13 | 25,00 | -540 750 | 537 925 |
| 2021-01-27 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 16 630 | 43 147 | 62,71 | 9,09 | 151 167 | 392 206 | |
| 2021-01-13 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -5 808 | 26 517 | -17,97 | 24,07 | -139 817 | 638 349 |
| 2021-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 68 100 | 68 100 | |||||
| 2021-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
A - Award | 15 100 | 15 100 | |||||
| 2021-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
M - Exercise | -8 650 | 25 950 | -25,00 | ||||
| 2021-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
F - Taxes | -2 842 | 32 325 | -8,08 | 23,29 | -66 190 | 752 849 | |
| 2021-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 650 | 35 167 | 32,62 | ||||
| 2020-12-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 0 | -100,00 | ||||
| 2020-12-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 26 517 | -23,59 | 25,19 | -206 206 | 668 045 |
| 2020-12-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 34 702 | 30,87 | 3,42 | 27 993 | 118 681 | |
| 2020-11-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 8 185 | -50,00 | ||||
| 2020-11-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 26 517 | -23,59 | 21,03 | -172 131 | 557 653 |
| 2020-11-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 34 702 | 30,87 | 3,42 | 27 993 | 118 681 | |
| 2020-10-20 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -16 370 | 16 370 | -50,00 | ||||
| 2020-10-20 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -16 370 | 26 517 | -38,17 | 21,00 | -343 770 | 556 857 |
| 2020-10-20 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 16 370 | 42 887 | 61,73 | 3,42 | 55 985 | 146 674 | |
| 2020-09-18 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -21 250 | 77 874 | -21,44 | ||||
| 2020-09-18 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 21 250 | 26 517 | 403,46 | 3,42 | 72 675 | 90 688 | |
| 2020-09-16 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -267 | 0 | -100,00 | ||||
| 2020-09-16 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 267 | 5 267 | 5,34 | 3,42 | 913 | 18 013 | |
| 2020-08-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 32 740 | -20,00 | ||||
| 2020-08-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -2 521 | 5 000 | -33,52 | 22,80 | -57 479 | 114 000 |
| 2020-08-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -5 664 | 7 521 | -42,96 | 22,34 | -126 508 | 167 985 |
| 2020-08-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 40 925 | -16,67 | ||||
| 2020-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -2 371 | 5 000 | -32,17 | 26,85 | -63 669 | 134 266 |
| 2020-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -5 814 | 7 371 | -44,10 | 26,36 | -153 259 | 194 303 |
| 2020-07-06 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-06-23 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -9 670 | 21 876 | -30,65 | ||||
| 2020-06-23 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -9 670 | 5 000 | -65,92 | 25,00 | -241 750 | 125 000 |
| 2020-06-23 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 9 670 | 14 670 | 193,40 | 2,97 | 28 720 | 43 570 | |
| 2020-06-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 49 110 | -14,29 | ||||
| 2020-06-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 5 000 | -62,08 | 21,01 | -171 959 | 105 046 |
| 2020-06-02 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-05-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -13 281 | 31 546 | -29,63 | ||||
| 2020-05-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -13 281 | 5 000 | -72,65 | 24,00 | -318 744 | 120 000 |
| 2020-05-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 13 281 | 18 281 | 265,62 | 2,97 | 39 445 | 54 295 | |
| 2020-05-07 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 57 295 | -12,50 | ||||
| 2020-05-07 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 5 000 | -62,08 | 21,00 | -171 885 | 105 000 |
| 2020-05-07 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -13 281 | 44 827 | -22,86 | ||||
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -13 281 | 5 000 | -72,65 | 23,00 | -305 463 | 115 000 |
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 13 281 | 18 281 | 265,62 | 2,97 | 39 445 | 54 295 | |
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 65 480 | -11,11 | ||||
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 5 000 | -62,08 | 21,18 | -173 358 | 105 900 |
| 2020-04-21 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-03-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 73 665 | -10,00 | ||||
| 2020-03-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 5 000 | -62,08 | 21,00 | -171 885 | 105 000 |
| 2020-03-03 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 13 185 | 163,70 | 3,42 | 27 993 | 45 093 | |
| 2020-02-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -2 535 | 99 124 | -2,49 | ||||
| 2020-02-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -5 650 | 81 850 | -6,46 | ||||
| 2020-02-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -8 185 | 5 000 | -62,08 | 21,00 | -171 885 | 105 000 |
| 2020-02-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 2 535 | 13 185 | 23,80 | 3,42 | 8 670 | 45 093 | |
| 2020-02-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 5 650 | 10 650 | 113,00 | 3,42 | 19 323 | 36 423 | |
| 2020-01-10 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 121 300 | 121 300 | |||||
| 2020-01-10 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Restricted Stock Units |
A - Award | 34 600 | 34 600 | |||||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -11 941 | 58 108 | -17,05 | ||||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -5 000 | 101 659 | -4,69 | ||||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -11 941 | 5 000 | -70,49 | 22,00 | -262 702 | 110 000 |
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 11 941 | 16 941 | 238,82 | 2,97 | 35 465 | 50 315 | |
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 5 000 | 5 000 | 3,42 | 17 100 | 17 100 | ||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -4 951 | 70 049 | -6,60 | ||||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
M - Exercise | -8 185 | 106 659 | -7,13 | ||||
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -1 340 | 0 | -100,00 | 22,01 | -29 487 | |
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -21 466 | 1 340 | -94,12 | 21,84 | -468 914 | 29 272 |
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 4 951 | 22 806 | 27,73 | 2,97 | 14 704 | 67 734 | |
| 2019-12-31 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
M - Exercise | 8 185 | 17 855 | 84,64 | 3,42 | 27 993 | 61 064 | |
| 2019-01-04 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 180 000 | 180 000 | |||||
| 2018-05-11 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
S - Sale | X | -9 669 | 9 670 | -50,00 | 15,00 | -145 035 | 145 050 |
| 2018-01-08 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 105 000 | 105 000 | |||||
| 2017-01-05 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy |
A - Award | 75 000 | 75 000 | |||||
| 2016-01-12 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
| 2015-01-13 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (Right to Buy) |
A - Award | 75 000 | 75 000 | |||||
| 2014-04-18 |
|
4 | DRNA |
Dicerna Pharmaceuticals Inc
Employee Stock Option (right to buy) |
A - Award | 165 050 | 165 050 | |||||
| 2014-01-29 | 3 | DRNA |
Dicerna Pharmaceuticals Inc
Common Stock |
19 339 |